Corticosteroid Nasal Irrigation as Early Treatment of Olfactory Dysfunction in COVID-19: A prospective randomized controlled trial : Corticosteroid Nasal Irrigation as Early Treatment of Olfactory Dysfunction in COVID-19: A prospective randomized controlled trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: The eligible COVID-19 patients who admit at Ramathibodi Hospitel, Ramathibodi Hospital and Ramathibodi Chakri Naruebodindra Hospital with new onset smell loss who capable to perform nasal irrigation themselves. COVID-19, Anosmia, Hyposmia, Budesonide;COVID-19, Anosmia, Hyposmia, Budesonide
Phase: Phase 3
Recruitment Status: Recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 14-07-2021, Last updated: 2023-06-05

ICTRP ID:

TCTR20210714006
Nil Known

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007857195